We then evaluated the viability of MM cell lines when exposed to increasing concentrations of recombinant TRAIL protein, to corroborate the DR5 overexpression driven by BZ with a higher TRAIL sensitivity. The gene discussed is TNFRSF10B; the disease is Miyoshi myopathy.